Skip to main content
. 2016 Mar 17;7(16):22720–22732. doi: 10.18632/oncotarget.8150

Figure 2. Expression of CISD2 in different clinical stages of laryngeal squamous cell carcinoma (LSCC).

Figure 2

(A) Representative images of immunohistochemical staining for CISD2 in normal (control sections) LSCC tissues and different clinical stages of LSCC. (B) Average fold-change in the mean optical density (MOD) for CISD2 in different clinical stages of LSCC compared with normal laryngeal tissues. (C) The statistical analyses of the average MOD of CISD2 staining in the lymph node metastasis group and the lymph node metastasis-free group, *P < 0.05.